Advanced search
1 file | 350.38 KB Add to list

Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study

Sofie Dhaese (UGent) , Magalie De Kezel (UGent) , Maxime Callant, Jerina Boelens (UGent) , Liesbet De Bus (UGent) , Pieter Depuydt (UGent) and Jan De Waele (UGent)
(2018) JOURNAL OF CRITICAL CARE. 47. p.164-168
Author
Organization
Keywords
Antimicrobial resistance, Continuous infusion, Intermittent infusion, Piperacillin, Meropenem, Critically ill patients, CRITICALLY-ILL PATIENTS, INTENSIVE-CARE UNITS, PSEUDOMONAS-AERUGINOSA, INTRAVENOUS-INFUSION, INFECTION, BACTERIA, ANTIBIOTICS, MULTICENTER, TAZOBACTAM, STRATEGIES

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 350.38 KB

Citation

Please use this url to cite or link to this publication:

MLA
Dhaese, Sofie, et al. “Emergence of Antimicrobial Resistance to Piperacillin/Tazobactam or Meropenem in the ICU : Intermittent versus Continuous Infusion : A Retrospective Cohort Study.” JOURNAL OF CRITICAL CARE, vol. 47, 2018, pp. 164–68, doi:10.1016/j.jcrc.2018.07.003.
APA
Dhaese, S., De Kezel, M., Callant, M., Boelens, J., De Bus, L., Depuydt, P., & De Waele, J. (2018). Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study. JOURNAL OF CRITICAL CARE, 47, 164–168. https://doi.org/10.1016/j.jcrc.2018.07.003
Chicago author-date
Dhaese, Sofie, Magalie De Kezel, Maxime Callant, Jerina Boelens, Liesbet De Bus, Pieter Depuydt, and Jan De Waele. 2018. “Emergence of Antimicrobial Resistance to Piperacillin/Tazobactam or Meropenem in the ICU : Intermittent versus Continuous Infusion : A Retrospective Cohort Study.” JOURNAL OF CRITICAL CARE 47: 164–68. https://doi.org/10.1016/j.jcrc.2018.07.003.
Chicago author-date (all authors)
Dhaese, Sofie, Magalie De Kezel, Maxime Callant, Jerina Boelens, Liesbet De Bus, Pieter Depuydt, and Jan De Waele. 2018. “Emergence of Antimicrobial Resistance to Piperacillin/Tazobactam or Meropenem in the ICU : Intermittent versus Continuous Infusion : A Retrospective Cohort Study.” JOURNAL OF CRITICAL CARE 47: 164–168. doi:10.1016/j.jcrc.2018.07.003.
Vancouver
1.
Dhaese S, De Kezel M, Callant M, Boelens J, De Bus L, Depuydt P, et al. Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study. JOURNAL OF CRITICAL CARE. 2018;47:164–8.
IEEE
[1]
S. Dhaese et al., “Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study,” JOURNAL OF CRITICAL CARE, vol. 47, pp. 164–168, 2018.
@article{8579140,
  author       = {{Dhaese, Sofie and De Kezel, Magalie and Callant, Maxime and Boelens, Jerina and De Bus, Liesbet and Depuydt, Pieter and De Waele, Jan}},
  issn         = {{0883-9441}},
  journal      = {{JOURNAL OF CRITICAL CARE}},
  keywords     = {{Antimicrobial resistance,Continuous infusion,Intermittent infusion,Piperacillin,Meropenem,Critically ill patients,CRITICALLY-ILL PATIENTS,INTENSIVE-CARE UNITS,PSEUDOMONAS-AERUGINOSA,INTRAVENOUS-INFUSION,INFECTION,BACTERIA,ANTIBIOTICS,MULTICENTER,TAZOBACTAM,STRATEGIES}},
  language     = {{eng}},
  pages        = {{164--168}},
  title        = {{Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study}},
  url          = {{http://dx.doi.org/10.1016/j.jcrc.2018.07.003}},
  volume       = {{47}},
  year         = {{2018}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: